Abstract:The beta-catenin pathway plays a critical role in the pathogenesis of certain types of cancers. To gain insight into mechanisms by which altered receptor tyrosine kinases regulate cytoplasmic beta-catenin accumulation, the effect of an oncogenic receptor originated from Nantes (RON) variant on beta-catenin accumulation and the role of beta-catenin in RON-mediated tumorigenic activities were studied. In NIH3T3 cells harboring oncogenic variant RON Delta 160, increased beta-catenin accumulation with tyrosine phosphorylation and nuclear translocation was observed. Overexpression of RON Delta 160 also resulted in increased expression of beta-catenin target genes c-myc and cyclin D1. By analyzing cellular proteins that regulate beta-catenin stabilities, it was found that RON Delta 160 activates the protein disheveled (DVL) and inactivates glycogen synthase kinase-3 beta by Ser-9 residue phosphorylation. These effects were channeled by RON Delta 160-activated PI 3-kinase-AKT pathways that are sensitive to specific inhibitors, such as wortmannin, but not to other chemical inhibitors. Silencing RON Delta 160 expression by specific small interfering RNA blocked not only beta-catenin expression but also c-myc and cyclin D1 expression, suggesting that RON expression is required for the activation of the beta-catenin signaling pathway. Moreover, it was found that knockdown of the beta-catenin gene expression by small interfering RNA techniques reduces significantly the RON Delta 160-mediated NIH3T3 cell proliferation, focus-forming activities and anchorage-independent growth. Thus, the oncogenic RON variant regulates beta-catenin stabilities through activation of DVL and inactivation of glycogen synthase kinase-3 beta. The activated beta-catenin cascade is one of the pathways involved in tumorigenic activities mediated by the oncogenic RON variant.

Β -Catenin Activates the Growth Factor Endothelin-1 in Colon Cancer Cells

δ-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profiles

Mechanisms of Cytoplasmic β-Catenin Accumulation and Its Involvement in Tumorigenic Activities Mediated by Oncogenic Splicing Variant of the Receptor Originated from Nantes Tyrosine Kinase

Wnt/β-catenin Singal Transduction Pathway and Colorectal Cancer

Cathelicidin, An Antimicrobial Peptide Produced By Macrophages, Promotes Colon Cancer By Activating The Wnt/Beta-Catenin Pathway

Oncogenic Function of DACT1 in Colon Cancer Through the Regulation of Β-Catenin.

Positive inter-regulation between beta-catenin/T cell factor-4 signaling and endothelin-1 signaling potentiates proliferation and survival of prostate cancer cells.

β-catenin interacts with and inhibits NF-κB in human colon and breast cancer

Β-Catenin Overexpression is Associated with Gefitinib Resistance in Non-Small Cell Lung Cancer Cells.

Β-Catenin/tcf4 Complex Induces the Epithelial-to-mesenchymal Transition (Emt)-Activator ZEB1 to Regulate Tumor Invasiveness.

Wnt-independent Beta-Catenin Transactivation in Tumor Development.

Delta-catenin promotes the proliferation and invasion of colorectal cancer cells by binding to E-cadherin in a competitive manner with p120 catenin

Β‐catenin Regulates IRF3‐mediated Innate Immune Signalling in Colorectal Cancer

Connective Tissue Growth Factor Is Overexpressed in Esophageal Squamous Cell Carcinoma and Promotes Tumorigenicity through β-Catenin-T-cell Factor/Lef Signaling

Modulation Of Beta-Catenin Signaling By The Inhibitors Of Map Kinase, Tyrosine Kinase, And Pi3-Kinase Pathways

Data from Endothelin Promotes Colorectal Tumorigenesis by Activating YAP/TAZ

Endothelial NO Synthase-Dependent S-Nitrosylation of Β-Catenin Prevents Its Association with TCF4 and Inhibits Proliferation of Endothelial Cells Stimulated by Wnt3a

A Ctnnb1 enhancer transcriptionally regulates Wnt signaling dosage to balance homeostasis and tumorigenesis of intestinal epithelia

beta-Catenin regulates the expression of tenascin-C in human colorectal tumors

Egr-1 Promotes Cell Proliferation and Invasion by Increasing Β-Catenin Expression in Gastric Cancer.

Intracellular complement C5a/C5aR1 stabilizes β-catenin to promote colorectal tumorigenesis